DiaMedica Therapeutics Inc. (DMAC) SEC filings
DMAC SEC filings moved a median of +1.74% by the close. DMAC SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the DMAC overview →
56 measured DMAC SEC filing events.
Where these DMAC SEC filings landedvs 54 measured DMAC SEC filing reactions
| Middle 50% of DMAC SEC filing reactions | -3.09% to +4.29% |
|---|---|
| Median reaction (to close) | +1.74% |
| Measured reactions | 54 |
Point-in-time · zero look-ahead
Half of the 54 DMAC SEC filing events with a measured close landed between -3.09% and +4.29%; 57% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form S-8 DiaMedica Therapeutics | SEC filing · Form S-8 | +0.15% | +3.00% | |
| Form 8-K DiaMedica Therapeutics For: May 20 | SEC filing · Form 8-K | +0.00% | +2.43% | |
| Form 10-Q DiaMedica Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -1.71% | +1.40% | |
| Form 8-K DiaMedica Therapeutics For: May 06 | SEC filing · Form 8-K | -1.71% | +1.40% | |
| Form ARS DiaMedica Therapeutics For: Dec 31 | SEC filing · Form ARS | +1.82% | +3.35% | |
| Form DEF 14A DiaMedica Therapeutics For: May 20 | SEC filing · Form DEF | +1.82% | +3.35% | |
| Form DEFA14A DiaMedica Therapeutics | SEC filing · Form DEFA14A | +1.82% | +3.35% | |
| Form 8-K DiaMedica Therapeutics For: Mar 30 | SEC filing · Form 8-K | -3.36% | -5.18% | |
| Form 10-K DiaMedica Therapeutics For: Dec 31 | SEC filing · Form 10-K | -3.36% | -5.18% | |
| Form 8-K DiaMedica Therapeutics For: Jan 05 | SEC filing · Form 8-K | +0.00% | +6.75% | |
| Form 8-K DiaMedica Therapeutics For: Dec 18 | SEC filing · Form 8-K | -1.18% | -1.89% | |
| Form 10-Q DiaMedica Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +0.95% | — | |
| Form 8-K DiaMedica Therapeutics For: Nov 12 | SEC filing · Form 8-K | +0.95% | — | |
| Form EFFECT DiaMedica Therapeutics | SEC filing · Form EFFECT | +0.66% | -0.33% | |
| Form 10-Q DiaMedica Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +2.86% | +22.45% | |
| Form 8-K DiaMedica Therapeutics For: Aug 12 | SEC filing · Form 8-K | +2.86% | +22.45% | |
| Form S-3 DiaMedica Therapeutics | SEC filing · Form S-3 | +2.86% | +22.45% | |
| Form EFFECT DiaMedica Therapeutics | SEC filing · Form EFFECT | -3.21% | -1.93% | |
| Form 8-K DiaMedica Therapeutics For: Aug 04 | SEC filing · Form 8-K | -0.64% | +0.00% | |
| Form S-3 DiaMedica Therapeutics | SEC filing · Form S-3 | -2.04% | -0.96% | |
| Form D DiaMedica Therapeutics | SEC filing · Form D | -0.10% | +2.85% | |
| Form 8-K DiaMedica Therapeutics For: Jul 21 | SEC filing · Form 8-K | +10.71% | +8.10% | |
| Form 8-K DiaMedica Therapeutics For: Jul 17 | SEC filing · Form 8-K | -5.20% | +2.08% | |
| Form 8-K DiaMedica Therapeutics For: May 15 | SEC filing · Form 8-K | -2.16% | +6.60% | |
| Form 10-Q DiaMedica Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +2.56% | +2.30% | |
| Form 8-K DiaMedica Therapeutics For: May 13 | SEC filing · Form 8-K | +2.56% | +2.30% | |
| Form ARS DiaMedica Therapeutics For: Dec 31 | SEC filing · Form ARS | -1.41% | -7.51% | |
| Form DEF 14A DiaMedica Therapeutics For: May 15 | SEC filing · Form DEF | -1.41% | -7.51% | |
| Form DEFA14A DiaMedica Therapeutics | SEC filing · Form DEFA14A | -1.41% | -7.51% | |
| Form 10-K DiaMedica Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.00% | -13.17% | |
| Form 8-K DiaMedica Therapeutics For: Mar 17 | SEC filing · Form 8-K | +0.00% | -13.17% | |
| Form 8-K DiaMedica Therapeutics For: Feb 28 | SEC filing · Form 8-K | +0.00% | -1.81% | |
| Form 8-K DiaMedica Therapeutics For: Feb 20 | SEC filing · Form 8-K | -1.46% | -2.92% | |
| Form 10-Q DiaMedica Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -0.93% | -3.96% | |
| Form 8-K DiaMedica Therapeutics For: Nov 13 | SEC filing · Form 8-K | -0.93% | -3.96% | |
| Form 10-Q DiaMedica Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +2.13% | +2.13% | |
| Form 8-K DiaMedica Therapeutics For: Aug 07 | SEC filing · Form 8-K | +2.13% | +2.13% | |
| Form EFFECT DiaMedica Therapeutics | SEC filing · Form EFFECT | +0.62% | +0.31% | |
| Form S-3 DiaMedica Therapeutics | SEC filing · Form S-3 | +0.00% | +6.31% | |
| Form D DiaMedica Therapeutics | SEC filing · Form D | +0.00% | +2.85% | |
| Form 8-K DiaMedica Therapeutics For: Jun 25 | SEC filing · Form 8-K | -2.33% | +14.73% | |
| Form 8-K DiaMedica Therapeutics For: Jun 26 | SEC filing · Form 8-K | -2.33% | +14.73% | |
| Form S-8 DiaMedica Therapeutics | SEC filing · Form S-8 | -1.75% | -0.35% | |
| Form 8-K DiaMedica Therapeutics For: May 22 | SEC filing · Form 8-K | — | +0.35% | |
| Form 10-Q DiaMedica Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -5.79% | -3.56% | |
| Form 8-K DiaMedica Therapeutics For: May 08 | SEC filing · Form 8-K | -5.79% | -3.56% | |
| Form 8-K DiaMedica Therapeutics For: Apr 05 | SEC filing · Form 8-K | +0.00% | -4.87% | |
| Form EFFECT DiaMedica Therapeutics | SEC filing · Form EFFECT | -1.48% | -1.85% | |
| Form ARS DiaMedica Therapeutics For: Dec 31 | SEC filing · Form ARS | -0.71% | +4.61% | |
| Form DEF 14A DiaMedica Therapeutics For: May 22 | SEC filing · Form DEF | -0.71% | +4.61% | |
| Form DEFA14A DiaMedica Therapeutics | SEC filing · Form DEFA14A | -0.71% | +4.61% | |
| Form S-3 DiaMedica Therapeutics | SEC filing · Form S-3 | -5.24% | +3.00% | |
| Form 10-K DiaMedica Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.00% | -3.15% | |
| Form 8-K DiaMedica Therapeutics For: Mar 19 | SEC filing · Form 8-K | +0.00% | -3.15% | |
| Form 10-Q DiaMedica Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +6.84% | +17.93% | |
| Form 8-K DiaMedica Therapeutics For: Nov 13 | SEC filing · Form 8-K | +6.84% | +17.93% |
Keep exploring
More DMAC: earnings → · analyst actions → · DMAC overview →